Pembrolizumab in endometrial cancer: Where we stand now

被引：13

作者：

Aravantinou-Fatorou, Aikaterini ^{[1
]}

Andrikopoulou, Angeliki ^{[2
]}

Liontos, Michael ^{[2
]}

Fiste, Oraianthi ^{[2
]}

Georgakopoulou, Vasiliki E. ^{[1
]}

Dimopoulos, Meletios-Athanasios ^{[2
]}

Gavriatopoulou, Maria ^{[2
]}

Zagouri, Flora ^{[2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Laiko Gen Hosp, Dept Med 1, Athens 11527, Greece

[2] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, 80 Vasilissis Sofias Ave, Athens 11528, Greece

来源：

ONCOLOGY LETTERS | 2021年 / 22卷 / 06期

关键词：

endometrial cancer; anti-PD1; treatment; polymerase epsilon-mutated cancer; microsatellite instability; biomarkers; ANTITUMOR ACTIVITIES; PD-L1; EXPRESSION; THERAPY; IMMUNOTHERAPY; CARCINOMA; CHEMOTHERAPY; INHIBITOR; RADIATION; SAFETY; IPILIMUMAB;

D O I：

10.3892/ol.2021.13082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recently, immunotherapy has shown promising results in solid tumors. To the best of our knowledge, this is the first systematic review of published literature synthesizing all the available data and evaluating both the efficacy and safety of pembrolizumab in endometrial cancer. The present study was performed in accordance with the PRISMA guidelines. Eligible articles were identified by searching the MEDLINE and ClinicalTrials.gov databases, using a predefined combination of the terms 'endometrial cancer' and 'pembrolizumab'. Overall, nine articles incorporating data from 712 patients were eligible. Pembrolizumab was demonstrated to be an effective and safe therapeutic option for the management of advanced/metastatic endometrial cancer. Results of ongoing trials evaluating either pembrolizumab alone or in combination with other antineoplastic regimens are expected to confirm its efficacy in this setting of patients. Pembrolizumab appears to be both durable and robust in endometrial cancer. However, there is an emerging need for novel predictive biomarkers to guide clinical practice.

引用

页数：12

共 77 条

[1] PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome [J].

Alsaab, Hashem O. ;

Sau, Samaresh ;

Alzhrani, Rami ;

Tatiparti, Katyayani ;

Bhise, Ketki ;

Kashaw, Sushil K. ;

Iyer, Arun K. .

FRONTIERS IN PHARMACOLOGY, 2017, 8

[2]

An examination of toxicity and treatment efficacy in clinical practice Presented at: The virtual 2021 SGO Annual Meeting on Womens Cancer

[3]

March 19-25 2021, 2021, VIRT 2021 SGO ANN M

[4] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[5] Endometrial cancer: Molecular markers and management of advanced stage disease [J].

Arend, Rebecca C. ;

Jones, Bayley A. ;

Martinez, Alba ;

Goodfellow, Paul .

GYNECOLOGIC ONCOLOGY, 2018, 150 (03) :569-580

[6] Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis [J].

Barrington, David A. ;

Dilley, Sarah E. ;

Smith, Haller J. ;

Straughn, J. Michael, Jr. .

GYNECOLOGIC ONCOLOGY, 2019, 153 (02) :381-384

[7] Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+T cell responses in endometrial cancer patients [J].

Bellone, Stefania ;

Centritto, Floriana ;

Black, Jonathan ;

Schwab, Carlton ;

English, Diana ;

Cocco, Emiliano ;

Lopez, Salvatore ;

Bonazzoli, Elena ;

Predolini, Federica ;

Ferrari, Francesca ;

Silasi, Dan-Arin ;

Ratner, Elena ;

Azodi, Masoud ;

Schwartz, Peter E. ;

Santin, Alessandro D. .

GYNECOLOGIC ONCOLOGY, 2015, 138 (01) :11-17

[8]

Bourla AB, 2016, ONCOLOGY-NY, V30, P59

[9] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[10] Current recommendations and recent progress in endometrial cancer [J].

Brooks, Rebecca A. ;

Fleming, Gini F. ;

Lastra, Ricardo R. ;

Lee, Nita K. ;

Moroney, John W. ;

Son, Christina H. ;

Tatebe, Ken ;

Veneris, Jennifer L. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (04) :258-279

← 1 2 3 4 5 6 7 8 →